Key result
Adiponectin treatment significantly reduced the E/E' ratio from 40.82 to 29.73 and attenuated diastolic dysfunction and cardiac hypertrophy in mice subjected to transverse aorta constriction.
Why the study?
The effects of adiponectin on diastolic dysfunction in a pressure overload model induced by transverse aorta constriction remained to be elucidated.
Does adiponectin improve diastolic function and cardiac hypertrophy in a mouse model of transverse aorta constriction?
Does adiponectin improve diastolic function and cardiac hypertrophy in a mouse model of transverse aorta constriction?
Absolute Event Rate: 29.73% vs 40.82%
p-value: p=<0.01
Adiponectin attenuates pressure overload-induced diastolic dysfunction and cardiac hypertrophy in mice by modulating titin isoform shift and reducing fibrosis via the AMPK pathway.
Does not support clinical use; hypothesis-generating for adiponectin in pressure-overload diastolic dysfunction.
Diastolic dysfunction is common in various cardiovascular diseases, which could be affected by adiponectin (APN). Nevertheless, the effects of APN on diastolic dysfunction in pressure overload model induced by transverse aorta constriction (TAC) remain to be further elucidated. Here, we demonstrated that treatment of APN attenuated diastolic dysfunction and cardiac hypertrophy in TAC mice. Notably, APN also improved active relaxation of adult cardiomyocytes, increased N2BA/N2B ratios of titin isoform, and reduced collagen type I to type III ratio and lysyl oxidase (Lox) expressions in the myocardial tissue. Moreover, APN supplementation suppressed TAC-induced oxidative stress. In vitro, inhibition of AMPK by compound C (Cpc) abrogated the effect of APN on modulation of titin isoform shift and the anti-hypertrophic effect of APN on cardiomyocytes induced by AngII. In summary, our findings indicate that APN could attenuate diastolic dysfunction in TAC mice, which are at least partially mediated by AMPK pathway.
No takes yet. Share an insight, caveat, or question.
Han et al. (2019) studied Diastolic dysfunction and cardiac hypertrophy (TAC model) (n=36). Adiponectin (APN) vs. Physiological saline (TAC group) was evaluated on E/E' ratio (p=<0.01). Adiponectin treatment significantly reduced the E/E' ratio from 40.82 to 29.73 and attenuated diastolic dysfunction and cardiac hypertrophy in mice subjected to transverse aorta constriction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: